MedTrace Logo

Ovarian PRP for Diminished Ovarian Reserve

NCT05790655 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2025-02-13

No results posted yet for this study

Summary

This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.

Conditions

  • Diminished Ovarian Reserve

Interventions

OTHER

oPRP

Prepared sample from patient's own blood collected and processed. Either PRP or serum is injected into the patient's ovary. All other care is standard for the IVF process

OTHER

Placebo- Serum

Patient's serum is injected into ovary instead of PRP as placebo

Sponsors & Collaborators

  • Igenomix

    collaborator INDUSTRY

  • Generation Next Fertility

    lead OTHER

Principal Investigators

  • Jesse Hade, MD · Generation Next Fertility

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-07
Primary Completion
2025-03-01
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05790655 on ClinicalTrials.gov